BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 2841264)

  • 21. WR-2721 as cytotoxic and radioprotective agent in treatment of murine lymphoma with total body irradiation.
    Coia LR; Brown DQ; Hardiman J
    NCI Monogr; 1988; (6):235-9. PubMed ID: 2832762
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sodium hydrogen-S-(3-amino-2-hydroxypropyl) phosphorothioate (WR-77913): toxicity and bone marrow radioprotection.
    Mendiondo OA; Connor AM; Grigsby P
    Int J Radiat Oncol Biol Phys; 1982; 8(3-4):553-5. PubMed ID: 6286552
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Protection of mouse bone marrow by Si-WU-Tang against whole body irradiation.
    Hsu HY; Ho YH; Lin CC
    J Ethnopharmacol; 1996 Jun; 52(2):113-7. PubMed ID: 8735456
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Protection by WR-2721 and WR-151327 against late effects of gamma rays and neutrons.
    Grdina DJ; Garnes BA; Nagy B
    Adv Space Res; 1992; 12(2-3):257-63. PubMed ID: 11537016
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Protection of normal tissues by WR2721 during fractionated irradiation.
    Utley JF; Phillips TL; Kane LJ
    Int J Radiat Oncol Biol Phys; 1976; 1(7-8):699-703. PubMed ID: 185172
    [No Abstract]   [Full Text] [Related]  

  • 26. Toxicity and radiation protective effect of WR-77913 in BALB/c mice.
    Mendiondo OA; Connor AM; Grigsby P
    Acta Radiol Oncol; 1982; 21(5):319-23. PubMed ID: 6297251
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Purging of small cell lung cancer cells from human bone marrow using ethiofos (WR-2721) and light-activated merocyanine 540 phototreatment.
    Meagher RC; Rothman SA; Paul P; Koberna P; Willmer C; Baucco PA
    Cancer Res; 1989 Jul; 49(13):3637-41. PubMed ID: 2543500
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Protection from radiation-induced apoptosis by the radioprotector amifostine (WR-2721) is radiation dose dependent.
    Ormsby RJ; Lawrence MD; Blyth BJ; Bexis K; Bezak E; Murley JS; Grdina DJ; Sykes PJ
    Cell Biol Toxicol; 2014 Feb; 30(1):55-66. PubMed ID: 24459009
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fractionation studies with WR-2721: normal tissues and tumour.
    Rojas A; Stewart FA; Soranson JA; Smith KA; Denekamp J
    Radiother Oncol; 1986 May; 6(1):51-60. PubMed ID: 3012656
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Protection of mice against mixed fission neutron-gamma (n: gamma = 1:1) irradiation by WR-2721, 16,16-dimethyl PGE2, and the combination of both agents.
    Steel LK; Walden TL; Hughes HN; Jackson WE
    Radiat Res; 1988 Sep; 115(3):605-8. PubMed ID: 2845467
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Differential protection against cytotoxic chemotherapeutic effects on bone marrow CFUs by Wr-2721.
    Wasserman TH; Phillips TL; Ross G; Kane LJ
    Cancer Clin Trials; 1981; 4(1):3-6. PubMed ID: 6260393
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Radioprotection of pronormoblasts and normoblasts by WR-2721.
    Naruka K; Bhartiya HC
    Strahlenther Onkol; 1990 Aug; 166(8):542-4. PubMed ID: 2168582
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Selenium pretreatment enhances the radioprotective effect and reduces the lethal toxicity of WR-2721.
    Weiss JF; Hoover RL; Kumar KS
    Free Radic Res Commun; 1987; 3(1-5):33-8. PubMed ID: 2854528
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Enhancement of bone marrow radioprotection and reduction of WR-2721 toxicity by Ocimum sanctum.
    Ganasoundari A; Devi PU; Rao BS
    Mutat Res; 1998 Feb; 397(2):303-12. PubMed ID: 9541656
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Protection by WR-2721 against radiation plus cis-diamminedichloroplatinum II caused injury to colonic epithelium in mice.
    Ito H; Komaki R; Milas L
    Int J Radiat Oncol Biol Phys; 1994 Mar; 28(4):899-903. PubMed ID: 8138443
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Computed tomographic assessment of radiation induced damage in the lung of normal and WR 2721 protected LAF1 mice.
    Miller GG; Dawson DT; Battista JJ
    Int J Radiat Oncol Biol Phys; 1986 Nov; 12(11):1971-5. PubMed ID: 3021694
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Interaction of misonidazole and WR-2721--II. Modification of tumour radiosensitization.
    Rojas A; Stewart FA; Denekamp J
    Br J Cancer; 1983 Jan; 47(1):65-72. PubMed ID: 6295429
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Modification of the radiation response of the mouse kidney by misonidazole and WR-2721.
    Williams MV; Denekamp J
    Int J Radiat Oncol Biol Phys; 1983 Nov; 9(11):1731-6. PubMed ID: 6315650
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Modification of tumour and host response to cyclophosphamide by misonidazole and by WR 2721.
    Twentyman PR
    Br J Cancer; 1981 Jun; 43(6):745-55. PubMed ID: 6264941
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of the radioprotective drugs MEA, DMSO, and WR-2721 on tumor control and skin tolerance in the rat.
    Moulder JE; Lo PS; Fischer JJ
    Cancer Treat Rep; 1977 Aug; 61(5):825-33. PubMed ID: 196752
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.